Słuzewski W - Search Results

1

[Current trends and first clinical studies of therapy for chronic hepatitis C in children using pegylated interferon alpha and ribavirin].

Słuzewski W, Mozer-Lisewska I, Figlerowicz M, Kowala-Piaskowska A, Słuzewska M. Słuzewski W, et al. Przegl Epidemiol. 2005;59(2):595-9. Przegl Epidemiol. 2005. PMID: 16190571 Review. Polish.

2

[Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin].

Mozer-Lisewska I, Dworacki G, Kaczmarek E, Słuzewski W, Kowala-Piaskowska A, Figlerowicz M, Kaczmarek M, Zeromski J. Mozer-Lisewska I, et al. Among authors: sluzewski w. Przegl Epidemiol. 2005;59(2):483-9. Przegl Epidemiol. 2005. PMID: 16190557 Polish.

3

[Effects of treatment with pegylated interferon and ribavirin in children with chronic hepatitis C].

Kowala-Piaskowska A, Figlerowicz M, Mozer-Lisewska I, Słuzewski W. Kowala-Piaskowska A, et al. Among authors: sluzewski w. Przegl Epidemiol. 2005;59(2):491-8. Przegl Epidemiol. 2005. PMID: 16190558 Polish.

4

[The clinical consequences of changes occurring in HCV population during the first weeks of chronic hepatitis C treatment with interferon and ribavirin].

Figlerowicz M, Formanowicz P, Kedziora P, Alejska M, Jackowiak P, Błazewicz J, Słuzewski W, Figlerowicz M. Figlerowicz M, et al. Among authors: sluzewski w. Przegl Epidemiol. 2005;59(2):581-90. Przegl Epidemiol. 2005. PMID: 16190569 Review. Polish.

5

[Expression of toll-like receptors on blood leucocytes of children with chronic viral hepatitis C].

Mozer-Lisewska I, Słuzewski W, Dworacki G, Kaczmarek M, Kowala-Piaskowska A, Figlerowicz M, Zeromski J. Mozer-Lisewska I, et al. Among authors: sluzewski w. Przegl Epidemiol. 2006;60(4):657-63. Przegl Epidemiol. 2006. PMID: 17682745 Polish.

6

Adverse effects during the treatment with pegylated interferon and ribavirin in children with chronic hepatitis C.

Kowala-Piaskowska A, Mozer-Lisewska I, Figlerowicz M, Słuzewski W. Kowala-Piaskowska A, et al. Among authors: sluzewski w. Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1095-103. doi: 10.1002/pds.1458. Pharmacoepidemiol Drug Saf. 2007. PMID: 17724740

7

Treatment of chronic hepatitis C in children with pegylated interferon α2a and ribavirin--a multi-center study.

Słuzewski W, Kowala-Piaskowska A, Wysocki J, Figlerowicz M, Gorczyca A, Halota W, Jóźwiak H, Mizerski J, Mozer-Lisewska I, Pawłowska M, Rokitka M, Strawińska E, Szamotulska K. Słuzewski W, et al. Acta Pol Pharm. 2012 Mar-Apr;69(2):319-26. Acta Pol Pharm. 2012. PMID: 22568047 Free article.

8

Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin.

Kowala-Piaskowska A, Słuzewski W, Figlerowicz M, Mozer-Lisewska I. Kowala-Piaskowska A, et al. Among authors: sluzewski w. Infection. 2007 Jun;35(3):175-9. doi: 10.1007/s15010-007-6072-5. Infection. 2007. PMID: 17565459 Clinical Trial.

9

Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis C.

Mozer-Lisewska I, Słuzewski W, Ali Youseif K, Figlerowicz M, Kowala-Piaskowska A. Mozer-Lisewska I, et al. Among authors: sluzewski w. Eur J Pediatr. 2003 Nov;162(11):755-9. doi: 10.1007/s00431-002-1147-x. Epub 2003 Aug 22. Eur J Pediatr. 2003. PMID: 12937972

10

Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C.

Figlerowicz M, Sluzewski W, Kowala-Piaskowska A, Mozer-Lisewska I. Figlerowicz M, et al. Among authors: sluzewski w. Eur J Pediatr. 2004 Apr;163(4-5):265-7. doi: 10.1007/s00431-004-1418-9. Epub 2004 Feb 27. Eur J Pediatr. 2004. PMID: 14991399 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters